|
2024
|
Invention
|
Dynamic output bias signal for a single photon avalanche diode (spad) based photon detection circ... |
|
2023
|
Invention
|
Materials and methods for inducing regulatory t cells.
The present invention concerns a structur... |
|
2021
|
Invention
|
Methods of treating influenza a virus infections.
Methods of treating influenza A are provided, ... |
|
2019
|
Invention
|
Islet cell engraftment. A composition of polymer particles, wherein the polymer particles are loa... |
|
2018
|
Invention
|
Materials and methods for inducing regulatory t cells. + T cells. This TGF-β mimic shares no homo... |
|
|
Invention
|
Staphylococcal antigens.
The present invention provides novel sequences encoding Staphylococcus ... |
|
2016
|
Invention
|
Methods for producing hepatocytes. Methods for producing hepatocytes from pluripotent human stem ... |
|
|
Invention
|
3,3-disubstituted-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1h-pyrazol-4-yl)-thiophen-3-yl]-methanones a... |
|
|
Invention
|
Nucleic acid editing systems. The present invention provides improved methods for generating nucl... |
|
|
Invention
|
Assay construct. Disclosed herein are systems, constructs, methods and assays for use in assessin... |
|
2013
|
Invention
|
Stem cell culture with modulators of the g protein signal transduction pathway. The present inven... |
|
2012
|
Invention
|
Amido-thiophene compounds and their use. The present invention pertains generally to the field of... |
|
|
Invention
|
Production of enantiomerically purified amino acids.
The present application relates to a mutate... |
|
|
Invention
|
Production of enantiomerically purified amino acids. The present application relates to a mutated... |
|
|
Invention
|
Weight related disorders. The present invention concerns the finding that expression of the gene ... |
|
2011
|
Invention
|
Plant cell lines and methods of isolating the same. An isolated plant cell having increased expre... |
|
|
Invention
|
3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thioph... |
|
2010
|
Invention
|
(4-phenyl-piperidin-1-yl)-[5-(1h-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use. ... |
|
|
Invention
|
(4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanone compounds and their use. Th... |
|
|
Invention
|
Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metab... |
|
|
Invention
|
Nucleic acid molecule. We describe non-naturally occuring synthetic genes and their use in a vacc... |
|
2008
|
Invention
|
Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors. The present invention pertain... |
|
|
Invention
|
Pluripotency determining factors and uses thereof.
Pluripotency determining factors are describe... |
|
|
Invention
|
Propagation and/or derivation of embryonic stem cells. Embryonic stem (ES) cells are cultured in ... |
|
|
Invention
|
Control of es cell self renewal and lineage specification, and medium therefor.
Self renewal of ... |
|
2007
|
Invention
|
Isolation, selection and propagation of animal transgenic stem cells. Animal stem cells are obtai... |
|
|
Invention
|
Treatment of myocardial infarction with 11hsd1 inhibitors.
The present invention relates to a me... |
|
2006
|
Invention
|
1,5-substituted tetrazoles as therapeutic compounds. The present invention pertains to certain 1,... |
|
|
Invention
|
Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome... |
|
2005
|
Invention
|
Treatment of myocardial infarction with 11hsd1 inhibitors. The present invention relates to a met... |
|
2004
|
Invention
|
Treatment of inflammation with 5α reduced metabolites. The present invention relates to the modul... |
|
|
Invention
|
Composition.
We provide a composition comprising a first agent which is an antagonist of 11β-HSD... |
|
2003
|
Invention
|
Thymic epithelial progenitor cells and uses thereof. A method for improving the viability of a po... |
|
|
Invention
|
Regulation of glucocorticoid concentration. The invention relates to use of a modulator of glucoc... |
|
|
Invention
|
Modulation of activation of glucocorticoid receptors &bgr;-breakdown products of glucocorticoids.... |
|
|
Invention
|
Par-2-activating peptide derivative and pharmaceutical composition using the same. 2, and relates... |
|
|
Invention
|
Pluripotency determining factors and uses thereof. Pluripotency determining factors are described... |
|
1999
|
Invention
|
Expression of heterologous genes according to a targeted expression profile. A gene trap vector c... |
